Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer

Ann Nutr Metab. 2019;75(4):223-230. doi: 10.1159/000504874. Epub 2019 Dec 19.

Abstract

Background: Cancer and aging are both frequently associated with malnutrition, a factor of poor prognosis. In adult cancer patients, this may be related in part to impaired energy metabolism, with higher than predicted resting energy expenditure (REE) in about 50% of patients. We hypothesized that frequently impaired energy metabolism in elderly patients could potentiate cancer-associated hypermetabolism, further promoting risk of malnutrition.

Objective: To study the hypermetabolic response to cancer in a predominantly aged population and the potential underlying determinants.

Methods: This was a cross-sectional exploratory study in patients with non-small-cell lung cancer. REE was measured by indirect calorimetry. Body composition was determined from a single CT scan imaging at L3 level. Endocrine, inflammatory, nutritional and metabolic status were evaluated.

Results: Twenty-seven patients, of median age 68 years (range 32-81) completed the study. In this population, mean measured REE was 7.5% higher than calculated REE. Sex and weight accounted for about 51% of REE variations, whereas age accounted only for 4%. However, these parameters did not explain the REE-to-lean body mass (LBM) ratio variations, suggesting that they influenced REE only through their effect on LBM. Among the other parameters evaluated, only the thyroid-stimulating hormone and interleukin-6 plasma levels appeared to have an influence on REE. The study of the consequences of this increase in REE-to-LBM ratio showed a growing inability of patients to meet their energy needs but showed no effect on nutritional markers such as transthyretin.

Conclusions: The results of this pilot study suggest that in our population, age was not an important factor of REE. The elevated energy metabolism was associated with patients' failure to increase their energy intakes sufficiently, which can contribute to the development of cachexia.

Clinical trial: This trial is registered at clinicaltrials.gov under NCT0314.

Trial registration: ClinicalTrials.gov NCT03141957 NCT00000314 NCT03141957.

Keywords: Aging; Cancer; Hypermetabolism; Lean body mass; Resting energy expenditure.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Body Composition
  • Cachexia / blood
  • Cachexia / physiopathology
  • Carcinoma, Non-Small-Cell Lung / blood
  • Carcinoma, Non-Small-Cell Lung / physiopathology*
  • Cross-Sectional Studies
  • Energy Metabolism*
  • Female
  • Humans
  • Interleukin-6 / blood
  • Lung Neoplasms / blood
  • Lung Neoplasms / physiopathology*
  • Male
  • Middle Aged
  • Nutrition Assessment
  • Pilot Projects
  • Prospective Studies
  • Rest*
  • Thyrotropin / blood

Substances

  • Interleukin-6
  • Thyrotropin

Associated data

  • ClinicalTrials.gov/NCT03141957
  • ClinicalTrials.gov/NCT00000314
  • ClinicalTrials.gov/NCT03141957